IQWiG's methods for the cost-benefit assessment. Comparison with an international reference scenario

被引:0
|
作者
Schwalm, A. [1 ]
Danner, M. [1 ]
Seidl, A. [1 ]
Volz, F. [1 ]
Dintsios, C. M. [1 ]
Gerber, A. [1 ]
机构
[1] IQWiG, D-51105 Cologne, Germany
关键词
Institute for Quality and Efficiency in Health Care; Health economic evaluation/methods; Reference case; Quality-adjusted life year (QALY); GENERAL-POPULATION; HEALTH; PREFERENCES; EFFICIENCY; DECISIONS; DRUGS; EQ-5D;
D O I
10.1007/s00103-010-1067-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Standardization of international health economic guidelines has been repeatedly requested. In this context, an international reference case was proposed, which constitutes an agreed approach for the key elements of health economic evaluation including study perspective, comparators, source of effectiveness data, role of modeling, main (economic) outcome, source of utilities, characterizing uncertainty. It is, however, questionable whether such a reference scenario can reasonably be applied across all health care systems. Our analysis pursues the question to which degree the Institute for Quality and Efficiency in Health Care's (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG)"General methods for evaluating the relation between cost and benefit" comply with the key elements of the reference case. In case of divergences, they will be described and discussed in light of the German social legislation and in consideration of current scientific evidence. In conclusion, the analysis revealed that IQWiG complied with the reference case in almost all aspects. Differences were found only with respect to the choice of main (economic) outcome and the source of utilities. These differences seem justified and well explained in the context of the German social legislation as well as in view of the weaknesses of the quality-adjusted life year (QALY) concept.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 50 条
  • [31] FUTURE METHODS FOR COST-BENEFIT ANALYSIS OF LABORATORY SYSTEMS
    HJELM, M
    SANDBLAD, B
    SCHUTT, T
    VERDIER, CHD
    OSTLING, G
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1974, 34 : 55 - 74
  • [32] Methods for determining cost-benefit ratios for pharmaceuticals in Germany
    J.- Matthias Graf v. d. Schulenburg
    Christoph Vauth
    Thomas Mittendorf
    Wolfgang Greiner
    The European Journal of Health Economics, 2007, 8 : 5 - 31
  • [33] Methods for determining cost-benefit ratios for pharmaceuticals in Germany
    Schulenburg, J. -Matthias Graf v. d.
    Vauth, Christoph
    Mittendorf, Thomas
    Greiner, Wolfgang
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (Suppl 1): : S5 - S31
  • [34] News of G-BA and IQWiG Current Methods of the early Benefit Assessment
    Lietz, Christine
    Wilken, Matthias
    PHARMAZEUTISCHE INDUSTRIE, 2013, 75 (04): : 582 - 588
  • [35] AGRIBUSSINESS PROJECTS ASSESSMENT USING COST-BENEFIT ANALYSES
    Filipovici, Alexandru
    Mnerie, Alin Vasile
    Badescu, Doina
    Bota, Mircea
    Maris, Simina
    Baesu, Viorica
    Slavici, Titus
    Ungureanu, Dragos
    AKTUALNI ZADACI MEHANIZACIJE POLJOPRIVREDE, 2014, 42 : 439 - 445
  • [36] COST-BENEFIT AND RELIABILITY ASSESSMENT OF ELECTRICAL GENERATING SYSTEMS
    ALLAN, RN
    SHAALAN, AM
    OCHOA, JR
    RELIABILITY ENGINEERING & SYSTEM SAFETY, 1986, 15 (01) : 1 - 19
  • [37] Cost-Benefit Assessment Related to Assurance of Environmental Quality
    Huttmanova, Emilia
    MANAGEMENT 2012: RESEARCH IN MANAGEMENT AND BUSINESS IN THE LIGHT OF PRACTICAL NEEDS, 2012, : 510 - 515
  • [38] DIFFERENT STUDY RESULTS OF UTILITIES IN RELATION TO THE DOCUMENTING METHOD USED AND THE GUARANTEE OF LEGALLY COMPLIANT IQWIG RECOMMENDATIONS WITHIN THE FRAMEWORK OF A COST-BENEFIT ASSESSMENT
    Dintsios, C. M.
    Volz, F.
    Seidl, A.
    VALUE IN HEALTH, 2009, 12 (07) : A400 - A400
  • [39] Cost-benefit analysis to support decarbonization scenario for 2030: A case study in Italy
    Sofia, Daniele
    Gioiella, Filomena
    Lotrecchiano, Nicoletta
    Giuliano, Aristide
    ENERGY POLICY, 2020, 137
  • [40] Cost-benefit analysis of NbS using flood resilient scenario modelling (FReSMo)
    Narendr, Aishwarya
    Aithal, Bharath H.
    Das, Sutapa
    SUSTAINABLE AND RESILIENT INFRASTRUCTURE, 2023, 8 : 109 - 114